Pfizer coronavirus The vaccine is very effective for children between 12 and 15 years of age Reported on Wednesday.

Pfizer said in a press release that in a late-stage trial of more than 2,200 adolescents in the United States, none of the vaccinated people were infected with COVID-19. The results indicate that the Pfizer-BioNTech vaccine may be more effective in people between 12 and 15 years of age than in adults.

Pfizer has not yet released test data. CEO Albert Bourla said the company plans to submit the results to the FDA in the next few weeks.

If emergency authorization is obtained, Pfizer’s vaccine will be the first vaccine in the United States for children under 16 years of age.Public health expert Believe Vaccinating children is essential to achieving “herd immunity”-when so many people are immune to COVID-19, the virus will no longer spread effectively. If, as announced by Pfizer, the test results show that the vaccine is indeed safe and effective, President Joe Biden has called for high school-age students to be immunized in the fall of the United States and early fall of 2022.

Pfizer said the trial showed that the vaccine is safe in children aged 12 to 15, and its side effects are “usually consistent with those observed by participants aged 16 to 25.”

Pfizer’s vaccine First authorized for emergency use It served people 16 years and older in December, and since then, more than 75 million doses have been provided to Americans.A kind Clinical Trials It was discovered last fall that it was 95% effective in reducing adult COVID-19 infection; a recent study showed that, “real world“Since authorization.

Pfizer also stated in the announcement that it has begun vaccinating children aged 5 to 11 in a related global trial and will begin providing vaccines to a group of children aged 2 to 5 years old next week.